MedPath

GlaxoSmithKline GmbH & Co. KG

🇩🇪Germany
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

8

Active:6
Completed:0

Trial Phases

2 Phases

Phase 1:1
Not Applicable:1

Drug Approvals

7

CIMA_AEMPS:5
NMPA:2

Drug Approvals

Bupropion Hydrochloride Sustained-release tablets(Ⅱ)

Product Name
盐酸安非他酮缓释片(Ⅱ)
Approval Number
H20200004
Approval Date
Mar 3, 2020
NMPA

Bupropion Hydrochloride Sustained-release tablets(Ⅱ)

Product Name
盐酸安非他酮缓释片(Ⅱ)
Approval Number
H20200003
Approval Date
Mar 3, 2020
NMPA

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Not Applicable
1 (50.0%)
Phase 1
1 (50.0%)
No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.